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Purpose
Immunotherapies aiming to interfere with the immune
checkpoint molecule PD-1 (programmed death-1) and its
ligand PD-L1 are currently being investigated in several
clinical trials to treat cancer patients. Little is known about
the effect of age or cancer on peripheral immune cell
subsets or on their expression of PD-1 and PD-L1. The
aim of this study was to assess the differences in immune
cell subsets, focusing on PD-1 and PD-L1 expression,
between young and old healthy donors, as well as between
age-matched healthy donors and cancer patients.
Methods
A total of 123 peripheral immune cell subsets were ana-
lyzed by flow-cytometry using 30 unique markers. The
subsets included 9 standard subsets (CD4 and CD8
T cells, regulatory T cells (Treg), B cells, conventional
dendritic cells (cDC), plasmacytoid DC (pDC), natural
killer cells (NK), natural killer T cells (NKT), and myeloid
derived suppressor cell (MDSC)), and 114 subsets relating
to maturation and function. PD-1 and PD-L1 surface
expression was analyzed in all relevant subsets. The
frequency of immune cells were compared between young
(under age 40, n=11) and old (over age 40, n=15) appar-
ently healthy individuals to assess the effect of age.
To investigate the effect of cancer, the older healthy indivi-
duals were also compared to age matched patients with
several types of advanced cancer (over age 40, n=30).
Results
Compared to young healthy individuals, older subjects had
several notable differences, including lower levels of total
CD8 T cells and naïve CD8 T cells, and higher levels of
total NK cells and PD-1 positive CD4 T cells. Relative to
age-matched healthy individuals, advanced cancer patients
had noteworthy differences in several immune cell subsets,
such as higher levels of total CD8 T cells and PD-L1
positive MDSC, and lower levels of total B cells and PD-
L1 positive B cells.
Conclusions
The frequencies of several peripheral immune cell subsets,
including some that express PD-1 or PD-L1, are affected
by both age and cancer.
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